REQUEST A DEMO
Total
USD $0.00
Search more companies

Sindy Claro Medicina Especializada Ips S.A.S (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Pharmacies and Drug Stores | Couriers and Express Delivery Services
Full name: Sindy Claro Medicina Especializada Ips S.A.S Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Sindy Claro Medicina Especializada Ips S.A.S is based in Colombia, with the head office in Santa Marta. The company operates in the Ambulatory Health Care Services sector. The enterprise was incorporated on October 01, 2014. The company’s latest financial report indicates a net sales revenue increase of 15.77% in 2025. There was a total growth of 26.25% in Sindy Claro Medicina Especializada Ips S.A.S’s total assets over the same period. The net profit margin of Sindy Claro Medicina Especializada Ips S.A.S decreased by 0.53% in 2025.

Headquarters
Cl 26 32 80 Lc 2 Cc Marinelo Plaza
Santa Marta; Magdalena;

Contact Details: Purchase the Sindy Claro Medicina Especializada Ips S.A.S report to view the information.

Basic Information
Registered Capital:
Purchase the Sindy Claro Medicina Especializada Ips S.A.S report to view the information.
Financial Auditors:
Purchase the Sindy Claro Medicina Especializada Ips S.A.S report to view the information.
Incorporation Date:
October 01, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Sindy Claro Medicina Especializada Ips S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
15.77%
Total Operating Revenue
15.77%
Operating Profit
-8.33%
EBITDA
-9.28%
Net Profit/Loss for the Period
0.95%
Total Assets
26.25%
Total Equity
63.98%
Operating Profit Margin
-3%
Net Profit Margin
-0.53%
Return on Equity (ROE)
-6.8%
Debt / Equity
-39.84%
Quick Ratio
0.52%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?